22q13 deletion syndrome, also known as Phelan-McDermid syndrome, is a genetic disorder caused by deletions or rearrangements at the q terminal end, the long arm, of chromosome 22. Any abnormal variation in the q13 region that produces the significant features typical of a terminal deletion may be diagnosed as this syndrome, though researchers disagree about its exact definition. The Developmental Synaptopathies Consortium defines it by SHANK3 mutations, which appears to exclude terminal deletions. Large terminal deletions can be found by karyotype, but many are too small, so DNA microarray has become the usual diagnostic tool, with FISH still useful for mosaicism and chromosomal rearrangements.
Facts
Classification
ICD-10 ChapterXVII: Congenital Malformations, Deformations and Chromosomal Abnormalities 1 Communicable or Non-communicable Causative Agent
Causative Agent (category) First Described Sources
1. World Health Organization: ICD-10 Version:2019, Chapter XVII, Q90-Q99
World Health OrganizationCategory Q93Quote, Category Q93
Q93 Monosomies
View the Source 2. 22q13 deletion syndrome (Wikipedia)
Lead
is a genetic disorder caused by deletions or rearrangements on the q terminal end (long arm) of chromosome 22
Lead: disease category
22q13 deletion syndrome, known as Phelan-McDermid syndrome (PMS), is a genetic disorder caused by deletions or rearrangements on the q terminal end (long arm) of chromosome 22.
History section
The first case of PMS was described in 1985 by Watt et al., who described a 14-year-old boy with severe intellectual disability, mild dysmorphic features and absent speech, which was associated with terminal loss of the distal arm of chromosome 22.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.